Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Current Assets (2016 - 2026)

Insmed's Current Assets history spans 17 years, with the latest figure at $1.6 billion for Q1 2026.

  • Quarterly Current Assets rose 15.01% to $1.6 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Mar 2026, up 15.01% year-over-year, with the annual reading at $1.8 billion for FY2025, 10.64% up from the prior year.
  • Current Assets came in at $1.6 billion for Q1 2026, down from $1.8 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $2.1 billion in Q2 2025 to a low of $632.2 million in Q3 2022.
  • The 5-year median for Current Assets is $1.3 billion (2022), against an average of $1.3 billion.
  • Year-over-year, Current Assets crashed 35.01% in 2022 and then skyrocketed 84.88% in 2025.
  • Insmed's Current Assets stood at $1.3 billion in 2022, then fell by 27.04% to $929.1 million in 2023, then soared by 74.55% to $1.6 billion in 2024, then increased by 10.64% to $1.8 billion in 2025, then decreased by 10.09% to $1.6 billion in 2026.
  • Per Business Quant, the three most recent readings for INSM's Current Assets are $1.6 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.9 billion (Q3 2025).